A monoclonal antibody, A7R34, that recognizes the high-affinity interleukin 7 receptor (IL-7Ra) and blocks the binding between IL-7 and IL-7Ra has been produced. Cell surface staining with A7R34 demonstrated that IL-7Ra is expressed in both B-and T-cell lineages. In the bone marrow, immature B-lineage cells that do not express surface IgM were IL-7Ra+. In the thymus, IL-7Ra was detected in CD4-8-T cells and also in CD4 or CD8 single-positive cells but not in CD4+8+ double-positive cells. In the peripheral lymphoid tissues, both CD4 and CD8 single-positive cells were the manor cell types that express IL-7Ra. Addition of A7R34 to a long-term B-precursor-cell culture inhibited proliferation of the B-lineage cells, indicating that IL-7 is an absolute requirement for in vitro B-cell genesis. Consistent with this in vitro result, continuous nijection of A7R34 into an adult mouse resulted in a decrease of B-precursor cells and also of thymocytes, whereas a considerable fraction of mature B and T cells in the peripheral tissues persisted over 2 weeks of the experiment. When A7R34 iniection is started from day 14 of gestation, it is possible to produce mice that lack B cells. These results indicate that IL-7 is an essential molecule for generation of both B and T cells in murine bone marrow and thymus, respectively. Moreover, IL-7Ra would be the sole receptor system regulating these processes.
B-cell genesis in the adult mouse is regulated by a meshwork of stromal-cell components in the bone marrow (1, 2) . Establishment of the stromal-cell lines that can support B-cell genesis from multipotent hematopoietic stem cells facilitated identification of the molecules that are required for this process (3) (4) (5) (6) . Among a number of molecules that are expressed in the stromal-cell lines, interleukin 7 (IL-7) is the first molecule that has been shown to be able to induce proliferation of B-cell precursors (7, 8) . Initial use of recombinant IL-7 demonstrated that IL-7 can induce proliferation of pre-B cells (8) (9) (10) . Subsequent studies further demonstrated that IL-7, when used in combination with the stromal cell lines or the ligand for c-kit, can act on earlier stages of B precursors (11) (12) (13) (14) (15) . Besides the proliferative activity on B-precursor cells, it was reported that IL-7 induces proliferation of both mature and immature mouse T cells (16) (17) (18) (19) (20) (21) (22) . In fact, studies of mice that received continuous IL-7 injections or bore the IL-7 transgene indicate that elevation of IL-7 results in enormous expansion of both T and B cells (23) (24) (25) (26) .
Despite all such positive evidence suggesting the role of IL-7 in lymphopoiesis, whether IL-7 is a functional requirement for in vivo lymphocyte production is yet to be determined. To address this question, we have produced an antagonistic monoclonal antibody (mAb) to the high-affinity IL-7 receptor (IL-7Ra) (27) and have investigated its expression and function. Our 
study demonstrates that IL-7Ra is
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expressed in surface IgM-negative (sIgM-) B precursors and also CD4-8-, CD4+8-, and CD4-8+ T cells. In addition, an in vivo injection experiment using this mAb indicates that IL-7 is actually a functional requirement for generation of both T and B cells.
MATERIALS AND METHODS
Preparation of Murine IL-7R-Human IgGl Chimeric Protein. A cDNA fragment corresponding to the whole IL-7Ra coding region (28) was generated by reverse transcription-PCR amplification from mRNA of the IL-7-dependent pre-B cell line DW34 (29) . The primers used were 5'-CTCAGAAT-GATGGCTCTGGG and 5'-AATTCATTTGTTTTGG-TAAAAACTAGACAT as sense and antisense primers, respectively. The TrisHCl, pH 7.5/150 mM NaCl/1% Triton X-100/1 mM phenylmethylsulfonyl fluoride/leupeptin (1 ,ug/ml)/5 mM EDTA/0.1% NaN3] for 45 min on ice. The lysates were precleared overnight with 100 t,l of goat anti-rat immunoglobulin-conjugated Dynabeads (Dynal, Oslo), precipitated with A7R34-or anti-rat-immunoglobulin-conjugated Dynabeads, and subjected to SDS/PAGE under reducing conditions in 7.5% gels. After transferring to nitrocellulose membrane (Hybond-C, Amersham), the membrane was blocked with phosphate-buffered saline containing 5% (vol/vol) skim milk and 1% bovine serum albumin, incubated with horseradish peroxidase-conjugated avidin (Bio-Rad), and developed by the ECL detection reagent (Amersham).
Murine recombinant IL-7 (Intergen, Purchase, NY) was radiolabeled using a solid-phase iodination technique with Iodo-Beads (Pierce), by following the manufacturer's recommendation. The receptor binding assay was performed by the method of Park et al. (38) .
RESULTS
The spleen cells from a Wister rat that was immunized with the IL-7Ra-IgGl fusion protein was fused with X63.Ag8 cells as described (35) . The hybridoma supernatants were screened by a growth inhibition assay of the IL-7-dependent cell line DW34. Among several hybridoma clones that were selected by the initial screening, only A7R34 remained after the second recloning.
A series of specificity tests for A7R34 indicated that it recognizes an epitope near the ligand binding site of IL-7Ra. (i) A7R34 stained the CHO cells that were transfected with the pSRa vector containing the gene encoding N-terminal 281 aa of IL-7Ra but not those transfected with the control vector without the inserts (Fig. 1A) . (ii) Immunoprecipitation of the biotinylated surface protein of 70Z/3 cells by A7R34-coated magnetic beads gave a 75-to 80-kDa major band and two smaller bands (Fig. 1B) . The size of the major band precipitated by A7R is consistent with a previous report that 65-to 75-kDa and 150-to 160-kDa (the dimer form) bands were cross-linked to labeled (27, 28) . However, the nature of smaller bands, whether they are IL-7Ra-associated molecules or degradated products of IL-7Ra, is yet to be deter-A mined. (iii) A7R34 inhibited the binding of 125I-labeled IL-7 to DW34 as efficiently as unlabeled IL-7 (Fig. 1C) .
We next investigated the cell types expressing IL-7Ra. In the thymus, IL-7Ra expression was observed in CD4-8-double-negative T cells and also CD4+8-and CD4-8+ singlepositive cells, whereas no IL-7Ra+ cells could be detected in CD4+8+ double-positive cells ( Fig. 2A) . In the spleen and lymph node, IL-7R+ cells were present mostly in CD4+8-and CD4-8+ single-positive T cells (Fig. 2B and unpublished  observation) . In contrast to these peripheral organs, most IL-7Ra+ cells in the bone marrow were B220+ cells and the cells that express a high level of IL-7Ra were basically B220dulI cells (Fig. 2C) . Upon maturation to s,+ B cells, IL-7Ra expression is downregulated.
Because A7R34 blocks IL-7 binding to IL-7Ra, it is expected that all IL-7Ra-dependent processes are suppressed by this mAb. To test whether B-cell genesis in a WhitlockWitte type long-term culture (LTBM-W) (39) is dependent on IL-7, we added A7R34 (20 Mg/ml) to a LTBM-W 4 weeks after the initiation of culture. The proliferation of B220+ cells was blocked and they disappeared from the culture (data not shown). This indicates that B-cell genesis in a LTBM-W is absolutely dependent on IL-7Ra.
To investigate the in vivo role of IL-7Ra in lymphocyte production, 2 mg ofA7R34 was injected into 8-week-old mice every other day. Fourteen days after the initial injection, the cells in various lymphoid organs were counted and analyzed for the expression of surface markers (Fig. 3) . C2-7(y2aK), which does not react to normal lymphoid tissues, was injected as a class-matched control mAb. A7R34 injection resulted in a striking reduction of the B220+ cells in the bone marrow and also of the thymocytes, whereas a decrease of the lymphocytes in the spleen and lymph nodes was rather slight. B220dulls,u-and B220dullsiL+ populations in the bone marrow and CD4+8+ cells in the thymus were affected most profoundly, though all cell fractions decreased in the absolute number. Interestingly, despite such a big deficit of lymphocyte recruitment from the bone marrow and thymus, a considerable number of both T and B lymphocytes in the peripheral organs persisted.
While the results in Fig. 3 Fig. 4 indicate that B-cell-less mice can be produced by A7R34 injection when the injection is started at the embryonic stage. Thus, at least in the early life, interaction between IL-7 and IL-7Ra is essential for B-cell genesis. Ifthe same is true for B-cell genesis in the adult bone marrow, our results in Fig. 4 suggest that a half of spleen B cells can survive longer than 2 weeks. It is interesting to note that a small number of B220+S7+ cells are constantly generated even in the B-cell-less mice produced by A7R34 injection. Because IL-7-reactive B-cell progenitors are included in B220+S7+ population (36) , this indicates that the earliest part of B-cell differentiation from multipotent stem cells to the IL-7-reactive stage may occur without IL-7Ra.
The major T-cell populations that express IL-7Ra are CD4-8-immature thymocytes and CD4+8-and CD4-8+ single-positive T cells in the thymus and the peripheral lymphoid tissues. However, the level of IL-7Ra expression within each differentiation stage is variable (Fig. 2 ). Thus, whether the level of IL-7Ra expression in each T-cell fraction could be a marker reflecting a differentiation stage or a functional status is an important question. Our present result on IL-7Ra expression in T cells is consistent with a series of previous in vitro studies that demonstrated that IL-7 is able to stimulate proliferation of CD4-8-immature thymocytes and mature peripheral T cells and also to induce cytotoxic activity of CD8+ mature lymphocytes (16) (17) (18) (19) (20) (21) (22) . The present study demonstrates that IL-7Ra is functioning in T-cell production in the thymus. A nearly 30-fold reduction of the thymus cellularity was induced by A7R34 injection, and probably as a consequence of this, the number of peripheral T cells was also reduced to 20-40% ofthat in control animals. However, we cannot address the question of whether IL-7Ra plays a role in maintaining IL-7Ra+ cells in peripheral tissues because of the tremendous effect of A7R34 on T-cell recruitment in the peripheral organs. The fact that both CD4+ and CD8+ cells remained in the peripheral tissues after the long-term treatment ofA7R34 suggests that the role ofIL-7Ra in the peripheral tissues might be small.
By taking the IL-7Ra expression pattern in the thymus into consideration, it is clear that IL-7 plays an essential role in the proliferation of CD4-8-thymocytes. However, of note is the fact that a significant number of both CD4+8+ T cells and mature single-positive cells persist over 2 weeks oftreatment. Moreover, 107 thymocytes were present in the mice that received the continuous A7R34 injection from day 14 of the gestation, though no B cells were present in the bone marrow (the same mice shown in Fig. 4A) . Thus, if all IL-7Ra+ cells are accessible to the injected A7R34, it is likely that the role of IL-7 in T-cell genesis might be a redundant process involving other cytokines.
